Page 293 - FINAL PROGRAMME 2017

P-632 From prenatal diagnosis of fetal abnormality to preimplantation genetic diagnosis (PGD) by using next-generation sequencing (NGS) technologies: a case study for skeletal dysplasia PGD
D. Amoros1, S. González-Reig2, F. Galán3, V. Penacho4, H. Blanca5, N. Castejón6, L.A. Alcaraz7
1Bioarray, Bioinformatics, Elche Alicante, Spain
2Bioarray, PGS/PGD Manager, Elche Alicante, Spain
3Bioarray, Medical Director, Elche Alicante, Spain
4Bioarray, R&D+i Manager, Elche Alicante, Spain
5Bioarray, PGS/PGD, Elche Alicante, Spain
6Bioarray, Bioinformatics PhD student, Elche Alicante, Spain
7Bioarray, Founding Partner & Technical Manager, Elche Alicante, Spain
P-633 Accurate detection of small segmental aneuploidy using next generation screening in preimplantation genetic diagnose and screening (PGD/PGS)
Z. Shuang1, X. Pingyuan2, C. Dehua3, O. Qi4, L. Ge5
1Institute of Reproductive & Stem Cell Engineering, Research Department, Changsha- Hunan, China
2China and National Engineering and Research Center of Human Stem Cell, Research Department, Changsha, China
3Institute of Reproduction and Stem Cell Engineering- Central South University, Research Department, Changsha, China
4Reproductive and Genetic Hospital of Citic-Xiangya, Research department, Changsha, China 5Central South University, Institute of Reproduction and Stem Cell Engineering, Changsha, China
P-634 The likelihood of transferring a euploid embryo after PGD-Aneuploidy cycles depends not only on female age but also on the number of biopsied blastocysts
M. Cetinkaya1, M.A. Tufekçi1, C. Cinar Yapan1, C. Pirkevi1, S. Kahraman1
1Istanbul Memorial Hospital, Assisted Reproductive Technologies and Reproductive Genetics Center, Istanbul, Turkey
P-635 Patient characteristics in uence the outcome of embryo aneuploidy testing cycles
G. Cutts1, M. Simpkins1, K. Spath1, N. Kubikova1, S. Alfarawati1, D. Wells1, E. Fragouli1 1Reprogenetics UK, Institute of Reproductive Sciences, Oxford, United Kingdom
P-636 Embryo asymmetry on day 2 is associated with blastocyst mosaicism after trophectoderm biopsy
A. Rodríguez-Arnedo1, J. Ten1, M.C. Díaz-Martinez1, L. Martí-Ferri1, I. Ochando2, J.A. Ortiz3, J. Guerrero1, L. Cascales1, J. Llácer4, R. Bernabeu4
1Instituto Bernabeu, Embryology Dept., Alicante, Spain
2Instituto Bernabeu, Embryology Dept., Albacete, Spain
3Instituto Bernabeu Biotech, Molecular Biology Dept., Alicante, Spain 4Instituto Bernabeu, Reproductive Medicine, Alicante, Spain
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 293
POSTERS